Anti-inflammatory and cytoprotective actions of hydrogen sulfide: translation to therapeutics

JL Wallace, RW Blackler, MV Chan… - Antioxidants & redox …, 2015 - liebertpub.com
Significance: There is a rapidly expanding body of evidence for important roles of hydrogen
sulfide in protecting against tissue injury, reducing inflammation, and promoting repair …

[HTML][HTML] A multi-targeted approach to suppress tumor-promoting inflammation

AK Samadi, A Bilsland, AG Georgakilas… - Seminars in cancer …, 2015 - Elsevier
Cancers harbor significant genetic heterogeneity and patterns of relapse following many
therapies are due to evolved resistance to treatment. While efforts have been made to …

The role of inflammation in kidney cancer

AR de Vivar Chevez, J Finke, R Bukowski - Inflammation and Cancer, 2014 - Springer
Renal cell carcinoma (RCC) constitutes more than 90% of primary kidney tumors with the
development of metastatic disease in the lung, bone, liver, and brain. Clear-cell RCC …

COX‐2 inhibitors and gastric cancer

Z Wang, J Chen, J Liu - Gastroenterology research and practice, 2014 - Wiley Online Library
The evidence that cyclooxygenase‐2 (COX‐2) is upregulated and plays an important role in
carcinogenesis of gastric cancer has triggered the topic of COX‐2 inhibitors as …

Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats

JH Gao, SL Wen, S Feng, WJ Yang, YY Lu, H Tong… - Angiogenesis, 2016 - Springer
Abnormal angiogenesis is critical for portal hypertension in cirrhosis. Except for etiological
treatment, no efficient medication or regime has been explored to treat the early stage of …

Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis

JH Gao, SL Wen, WJ Yang, YY Lu, H Tong, ZY Huang… - PloS one, 2013 - journals.plos.org
Background Increased intra-hepatic resistance to portal blood flow is the primary factor
leading to portal hypertension in cirrhosis. Up-regulated expression of cyclooxygenase-2 …

[HTML][HTML] Paeonol exerts an anticancer effect on human colorectal cancer cells through inhibition of PGE2 synthesis and COX-2 expression

M Li, SY Tan, XF Wang - Oncology reports, 2014 - spandidos-publications.com
Abstract Cyclooxygenase-2 (COX-2) and its metabolite prostaglandin E2 (PGE2) can
potentially affect most of the events in cancer development, including promotion of …

Celecoxib attenuates hepatic cirrhosis through inhibition of epithelial‐to‐mesenchymal transition of hepatocytes

SL Wen, JH Gao, WJ Yang, YY Lu… - Journal of …, 2014 - Wiley Online Library
Abstract Background and Aim The epithelial–mesenchymal transition (EMT) of hepatocytes
is a key step for hepatic fibrosis and cirrhosis. Long‐term administration of celecoxib, a …

Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer

W Elsheikh, RW Blackler, KL Flannigan, JL Wallace - Nitric Oxide, 2014 - Elsevier
Regular use of nonsteroidal anti-inflammatory drugs is associated with a significantly lower
incidence of several types of cancer, particularly those affecting the gastrointestinal tract …

Pathway analysis for drug repositioning based on public database mining

Y Pan, T Cheng, Y Wang, SH Bryant - Journal of chemical …, 2014 - ACS Publications
Sixteen FDA-approved drugs were investigated to elucidate their mechanisms of action
(MOAs) and clinical functions by pathway analysis based on retrieved drug targets …